President Trump directed his administration to help states import drugs from Canada. But a proposal to alter a Medicare program to reduce costs could wind up raising prices.

In his first major action on health care costs this term, President Donald Trump issued a multi-part executive order on Tuesday aimed at lowering drug prices and reducing costs for Medicare. The move comes as his administration seeks to impose tariffs on pharmaceutical imports that many experts have said could lead to drug shortages and price hikes.

President Trump's wide-ranging executive order aimed at lowering pharmaceutical costs revives policies from his first term and alters programs started during the Biden administration — including making a drug industry-backed change to Medicare drug price negotiations.